Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(61 sites)
United States
Research Site, Los Angeles, California Clinical Research Site 4, Santa Clarita, California Clinical Research Site 6, Springfield, Illinois Research Site, Indianapolis, Indiana Research Site, Kansas City, Kansas Research Site, St Louis, Missouri Clinical Research Site 5, North Platte, Nebraska Clinical Research Site 3, Greensboro, North Carolina Research Site, Wilmington, North Carolina Clinical Research Site 7, Philadelphia, Pennsylvania Clinical Research Site 1, Mesquite, Texas Clinical Research Site 2, San Antonio, Texas Brazil
Research Site, Fortaleza, Ceará Research Site, Belo Horizonte, Minas Gerais Research Site, Belo Horizonte, Minas Gerais Research Site, Belo Horizonte, Minas Gerais Research Site, Porto Alegre, Rio Grande do Sul Research Site, Pôrto Alegre, Rio Grande do Sul Bulgaria
Research Site, Stara Zagora China
Research Center, Beijing, Beijing Municipality Research Site, Guiyang, Guizhou Research Site, Harbin, Heilongjiang Research Center, Baotou, Inner Mongolia Research Site, Chifeng, Inner Mongolia Research Center, Nanchang, Jiangxi Research Center, Shanghai, Shanghai Municipality Research Center, Hangzhou, Zhejiang Research Site, Hangzhou, Zhejiang Serbia
Research Center, Belgrade South Korea
Research Site, Jeonju, Jeollabuk-do Sweden
Research Center, Gothenburg Research Center, Stockholm United Arab Emirates
Research Site, Al Ain City